What is Insulin Aspart?
Category: Prescription Drugs
Most popular types: Novolog NovoLog FlexPen NovoRapid Show all
See also: Insulin Aspart Protamine
Insulin aspart is a rapid-acting insulin used for the treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) to improve glycemic control.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 1 | 1392 | 40 | |
| Diabetes type 2 | 173 | 36 | |
| Cystic fibrosis-related diabetes | 9 | 2 | |
| Elevated blood sugar (hyperglycemia) | 5 | 1 | |
| Latent autoimmune diabetes | 3 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 9 | |
| Mild | 23 | |
| None | 46 |
Commonly reported side effects and conditions associated with Insulin Aspart
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 15 | |
| Weight gain | 6 | |
| Injection site pain | 2 | |
| Reactive hypoglycemia | 2 | |
| Chronic hyperglycemia | 1 | |
| Chronic kidney disease | 1 |
Dosages
Based on patients currently taking Insulin Aspart
| Dosage | Patients | Percentage |
|---|---|---|
| 1 other daily | 1 | |
| 12 other daily | 1 | |
| 6 intl units three times daily | 1 | |
| 10 mcg twice daily | 1 | |
| 7 Units three times daily | 1 | |
| 25 other daily | 1 | |
| 10 intl units three times daily | 1 | |
| 15 intl units twice daily | 1 | |
| 30 mg daily | 1 | |
| 14 mg three times daily | 1 |
Duration
Currently taking Insulin Aspart
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 2 years | 1 | |
| 2 - 5 years | 5 | |
| 5 - 10 years | 2 | |
| 10 years or more | 6 |
Stopped taking Insulin Aspart
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 1 | |
| 6 months - 1 year | 7 | |
| 1 - 2 years | 7 | |
| 2 - 5 years | 8 | |
| 5 - 10 years | 7 | |
| 10 years or more | 3 |
What people switch to and from
Patients started taking Insulin Aspart after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Insulin Lispro (Humalog) | 13 | |
| Insulin Glargine (Lantus) | 8 | |
| Metformin (Metformin ER) | 6 | |
| Insulin NPH (Novolin N) | 5 | |
| Insulin NPH-insulin regular (Novolin Mix 70/30) | 3 |
Patients stopped taking Insulin Aspart and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Insulin Lispro (Humalog) | 9 | |
| insulin detemir (Levemir) | 3 | |
| Insulin Glargine (Lantus) | 2 | |
| Insulin Regular (Humulin R) | 2 | |
| Dulaglutide (Trulicity) | 1 |
Last updated: